Angi Inc. delivered a second quarter that, on its face, looks like a disaster: a $230.7 million net loss, a $5.70 diluted loss per share, an operating loss of $233.7 million, and a balance-sheet write-down that erased $235.2 million of acquired goodwill and trade names at the U.S. reporting unit. Read the impairment out and the quarter is also bad: revenue fell 11% to $248.0 million as the U.S. lead-generation business continued to bleed, and Adjusted EBITDA slipped 14% to $28.2 million. Read deeper and the second look is more interesting. The Q2 hit was almost entirely a single non-cash event triggered by Angi's collapsing stock price - management ran a quantitative impairment test because the share count had fallen from year-end, and the U.S. unit's carrying value no longer cleared its own market-based mark. The operating quarter, on the metrics management has long asked investors to track, was almost stable: U.S. Proprietary Revenue fell 10% to $198.1 million, but the new Large Pro and National Partnership bucket grew 20% for the second straight quarter; Product Development expense fell 54% to $10.9 million; the company opportunistically retired $73.4 million of 2028 senior notes for $68.0 million in cash, booking a $5.6 million gain; and the balance sheet ended with $188.7 million in cash, no revolver borrowings, and only $400.0 million of long-term debt remaining.
The market didn't wait for the second look. Following the August 4 print, the shares fell to $4.26 in the session a day later - a fresh 52-week low that is 77% below the $18.765 high the stock printed at the 1-for-10 reverse split's aftermath in early 2025. The total enterprise value is now roughly $387 million against $993 million of trailing revenue and $131 million of trailing Adjusted EBITDA - about 0.4x sales and 3.0x Adjusted EBITDA, with a 0.26x price/book on a balance sheet that just took a $235 million non-cash hit to its largest assets. This is a market that has already discounted the operating decline plus the possibility of a second impairment, plus the structural concerns about whether the legacy Network business ever recovers, plus the $400 million of senior notes maturing in twenty-six months. The thesis the second look supports is that the operating business - narrowed to U.S. Proprietary, Large Pro, and the new AI Front Desk agent - is generating cash and growing where it matters, while the next two quarters tell investors whether management's stated playbook (Pro Chief Revenue Officer, AI-native platform, Network rationalization) stabilizes the U.S. business or whether a second round of impairment charges is the more honest read.